The healthcare private equity investment landscape in 2025 is expected to be shaped by a mix of optimism and caution. Even with tariff-related uncertainty and a challenging macroeconomic, investor sentiment has strengthened since the start of the year, with many expecting steady or increased deal activity. A combination of attractive assets coming to market, record-long hold periods, and pressure from LPs is driving expectations for greater capital deployment. At the same time, tariffs, shifting reimbursement dynamics, and operational challenges are prompting investors to adopt a more rigorous and data-driven diligence approach.
Read the full article: Investing in Healthcare 2025: Stax PE Investor Survey //
Source: https://irp.cdn-website.com/bbd57769/files/uploaded/Stax+Healthcare+Investor+Survey+2025.pdf